Intelligence · Clinical pipeline
Autoimmune & immunology R&D Pipeline
Autoimmune, rheumatology, and immunology biologics in clinical development.
Quick answer
Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.
Top sponsors
- Takeda 87 programs
- Chinese Academy of 58 programs
- Anaxis Pharma 52 programs
- Janssen-Cilag International N.V 34 programs
- Novartis India 32 programs
- First People's Hospital 23 programs
- Lakefront Biotherapeutics NV 22 programs
- AbbVie 21 programs
- AbbVie Deutschland GmbH 20 programs
- Regeneron UK 20 programs
- HOFFMANN-LA ROCHE 19 programs
- Pacira Ireland 18 programs
Pipeline programs
-
GRT-1C101
Rani Therapeutics Holdings
Ulcerative colitis
1 trial -
GRT-1C102
Rani Therapeutics Holdings
Ulcerative colitis
1 trial -
GS-0272
Gilead Sciences Ireland UC
Rheumatoid Arthritis
1 trial -
HN2301 injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Lupus Erythematosus
1 trial -
HN2302 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Disease
1 trial -
Human Umbilical Mesenchymal Stem Cells
The First People's Hospital of Lianyungang
Osteoarthritis, Knee
1 trial -
Humanized TNFα monoclonal antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
IASO206 injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hemolytic Anemia
1 trial -
IM034-1000
Bristol-Myers Squibb Australia Pty Ltd
Subacute Cutaneous Lupus Erythematosus, Discoid Lupus Erythematosus, Systemic Lupus Erythematosus
1 trial -
IM060-0001
Bristol-Myers Squibb Australia Pty Ltd
Systemic Sclerosis, Idiopathic Inflammatory Myopathy, Rheumatoid Arthritis, Systemic Lupus Erythematosus
1 trial -
Ixazomib
Takeda
Lupus Nephritis
1 trial -
JADE201
Jade Biosciences
Rhematoid Arthritis
1 trial -
JANX011
Janux Therapeutics
Autoimmune
1 trial -
LCAR-AIO T cells
Nanjing Legend Biotech Co.
Relapsed/Refractory Autoimmune Diseases
1 trial -
LCAR-AIO T cells
Nanjing Legend Biotech Co.
Systemic Lupus Erythematosus (SLE)
1 trial -
LD and GC012F CAR-T Cell Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
LUCAR-DKS1 NK cells
Nanjing Legend Biotech Co.
Relapsed/Refractory Autoimmune Diseases
1 trial -
LUCAR-G79 T cells
Nanjing Legend Biotech Co.
Relapsed/Refractory Autoimmune Diseases
1 trial -
LUCAR-G79D T cells
Nanjing Legend Biotech Co.
Systemic Lupus Erythematosus (SLE)
1 trial -
LVIVO-TaVec400 product
Nanjing Legend Biotech Co.
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)
1 trial -
LX3305
LEXICON PHARMACEUTICALS, INC.
Rheumatoid Arthritis
1 trial -
Linperlisib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hemolytic Anemia
1 trial -
M25-433
AbbVie Deutschland GmbH & Co. KG
Systemic Lupus Erythematosus, Sjogren's disease
1 trial -
MC-1-50
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus (SLE)
1 trial -
MDGN-002
Avalo Therapeutics
Crohn Disease
1 trial -
MESAL-02-25
Lacuna Pharma Pty Ltd
ulcerative colitis
1 trial -
MESAL-03-25
Lacuna Pharma Pty Ltd
ulcerative colitis
1 trial -
MESAL-19-24
Lacuna Pharma Pty Ltd
ulcerative colitis
1 trial -
MESAL-20-24
Lacuna Pharma Pty Ltd
ulcerative colitis
1 trial -
MK-1045-004
Merck Sharp and Dohme
Systemic lupus erythematosus, Rheumatoid arthritis
1 trial -
MK-2420 SAD Study
Merck Sharp and Dohme
Rheumatoid arthritis
1 trial -
Methotrexate
Sana Biotechnology
Chronic Plaque Psoriasis
1 trial -
Methotrexate - Amneal
Amneal Pharma Europe Ltd
Psoriasis
1 trial -
Methotrexate PK (in combination with Novobiocin) in RA patients
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
Modified Gegen Qinlian Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
No Intervention
Takeda
Rheumatoid Arthritis
1 trial -
O3R-5671-CL-101
Lacuna Pharma Pty Ltd
Inflammatory bowel diseases and psoriasis.
1 trial -
Obecabtagene autoleucel (obe-cel)
Autolus GmbH
Systemic Lupus Erythematosus
1 trial -
PH-F8IL10INTRA-03/24
Philogen S.p.A.
Patients with Rheumatoid Arthritis (RA) who, despite treatment with stable doses (for at least 3 months) of disease-modifying antirheumatic drugs (DMARDs, conventional, biologic and/or targeted synthetic), present arthritis flare(s) suitable for intra-articular (IA) injection in a knee, shoulder, ankle, wrist or elbow.
1 trial -
PIPE-791
Contineum Therapeutics
Chronic Osteoarthritis Pain
1 trial -
PTOC1
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
Phase 1 study on SAR443122 bioavailability and food effect in healthy adults
Sanofi-aventis Healthcare Pty Ltd
Colitis ulcerative
1 trial -
Placebo
Nektar Therapeutics UK Limited
Psoriasis
1 trial -
QT-019C
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SLE - Systemic Lupus Erythematosus
1 trial -
R5459-1979-LN-2459
Lacuna Pharma Pty Ltd
Lupus Nephritis
1 trial -
RA-TL011-101
Teva Pharma GmbH
Rheumatoid Arthritis
1 trial -
REGN88
Regeneron UK Limited
Rheumatoid Arthritis
3 trials -
RO7507062
Hoffmann-La Roche
Systemic Lupus Erythematosus
1 trial
Frequently asked questions
How many autoimmune & immunology pipeline programs are tracked?
985 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.